ECHA consults on fragrance sensitisation concerns

The Swedish European Chemicals Agency has opened a public consultation for the classification and labelling (CLH) of hydroxyisohexyl 3-cyclohexene carboxaldehyde in a bid to determine its potential for causing skin sensitisation issues.

The chemical Hydroxyisohexyl 3-cyclohexene carboxaldehyde, also known as Lyral, is a multi-constituent substance widely used in consumer products, including cosmetics, detergents and room fresheners and has been submitted by the Member State to settle safety concerns over the substance.

"The ECHA is calling for input from interested parties, in English if possible, on the classification of the substance as an SVHC as well as data on use, exposure, alternatives and risk."

The substance has not been in the harmonised entries Part 3 of Annex VI to the CLP Regulation and the public consultation will be open for 45 days, set to end on 16 August to submit their comments. 

According to the Agency, the comments received will be published regularly on the ECHA website during the consultation period, and at the end of the round will be compiled into a list that will be part of the Opinion of the Committee for Risk Assessment (RAC).

"The CLH reports and the dedicated webform to post the comments are available on the ECHA website. The comments received during the public consultation will be regularly published on the ECHA website during the 45-day consultation phase."

After this public consultation, ECHA says the parties concerned will then be encouraged to coordinate their involvement in the RAC opinion-making process with the regular and sector-specific stakeholder observers.

The list of these stakeholders, the working procedure for their participation in the RAC meeting as well as the relevant agendas are available here. The agendas indicate the substances planned to be discussed at each RAC meeting. 

"Following the inclusion of the substance in Part 3 of Annex VI to the CLP Regulation, all manufacturers, importers and users of the substance in the EU shall classify the substance accordingly, enabling the ultimate users to be better informed about the substance, its potential effects and how best to make use of it safely."